Our podcast on markets, the economy and business. This week, an interview with David Ricks, CEO of Eli Lilly
Catch up on global daily news
Compelling long reads
Tune into captivating conversations
Watch engaging short films
Behind the scenes at The Economist
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
It will transform how medicines are made—and the industry itself
A new set of lists ranks drug company laboratories on two criteria: innovation and invention.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical…
To recover its lead in obesity drugs, the Danish giant is transforming itself
Eli Lilly has stopped disclosing its early-stage pipeline and most deal values as it grows larger. An analysis of why the…
